Clinical Trial Update: Everolimus With and Without Temozolomide in Adult Low Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating everolimus with and without temozolomide in adult low grade glioma has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma
• Mixed Oligodendroglioma and Astrocytoma
• Oligodendrogliomas
• World Health Organization Grade Ii Astrocytomas

Drugs mentioned

• Everolimus (everolimus)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas | Phase 2 | Status: TERMINATED | Results posted: 2022-12-29